Prof. Shane Crotty Profile picture
Aug 31, 2020 7 tweets 3 min read Read on X
1/ Our new paper is out: Multifaceted Effects of Antigen Valency on B Cell Responses In Vivo.
bit.ly/34MMKrJ
There is lots of excitement about nanoparticle vaccine designs, and a general consensus that multivalency is a good thing for vaccines. @ljiresearch @ImmunityCP Image
2/ But, mechanistic immunological understand of the impact of valency has been limited, for a variety of reasons. Here, we completed a four years study of valency and and affinity on antigen-specific B cell responses in vivo.
3/ We found that antigen valency dictates the magnitude and composition of B cell responses. Antigen valency alters breadth of B cell affinities recruited. And valency appears to modulate both the magnitude and the clonal compositions of GC responses.
4/ Under low-valency immunization, stringent affinity selection precluded most low-affinity B cell clones from participating in germinal center and plasma cell responses. Image
5/ In contrast, high valency immunization enabled B cell clones encompassing a broad range of affinities to efficiently participate in GCs! Image
6/ Valency altered the composition of the responding antigen-specific B cell population. Thus, the quantity and quality of B cell responses can be tuned by altering antigen valency, with important implications for vaccine design. Image
7/ Another enjoyable collaboration with the Schief lab at @scrippsresearch !

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Prof. Shane Crotty

Prof. Shane Crotty Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @profshanecrotty

Oct 4, 2022
Our new paper is out showing T cell responses to the Novavax vaccine, studying Novavax vaccine clinical trial participants, led by the outstanding Dr. @CModerbacher! With a nice commentary article by @PC_immuno . 🧵

jci.org/articles/view/…

jci.org/articles/view/…
This complements our immune memory study comparing 4 COVID vaccines, including Novavax.
Including direct CD4 and CD8 T cell memory comparisons

sciencedirect.com/science/articl…
Read 4 tweets
Sep 26, 2022
Our paper on immunization and long germinal centers is out in @Nature! Congrats to the indefatigable and brilliant JH Lee and @harrysutton93 ! 🧵
nature.com/articles/s4158…

And Free link: rdcu.be/cV2xv
We put together an extensive tweetorial of this study earlier:
And a deep dive into some of the cool immunological questions the experiments shed light on:
Read 6 tweets
Aug 31, 2022
The brand newly approved COVID boosters are going to work well. They won’t be a game changer—won’t prevent all infections—but are the best booster option and will provide a lot of protection.

It’s the immunity you want heading into the Fall and winter.

nytimes.com/2022/08/31/wel…
To clarify a few things and add some details:

The Omicron booster vaxs are clearly safe. Billions of Covid mRNA vax doses have been given, with excellent safety. Regarding the new “bivalent” boosters, there was a 2021 bivalent COVID booster vax human trial…
and it was safe and boosted immunity well. nature.com/articles/s4159…
Read 9 tweets
Jul 28, 2022
Wonderful workshop on Vaccine Durability questions today and yesterday with NIAID. Thanks to my session co-chair @TheBcellArtist, and the awesome panelists. There was intensive and wonderful discussion, and we did make several recommendations 👇🏼
The awesome panelists were @deeptabhattacha @KingLabIPD, Rama Amara, Kanta Subbarao, and Chris Chiu (are they on Twitter?)

The rapid fire recommendations at the end of the discussion:
What kind of studies that would bring us closer to addressing some of the knowledge gaps in engineering durable vaccine immune responses?
Read 10 tweets
Jul 19, 2022
It is good to see Novavax antibody data on Omicron 1,2,4 and 5 from @veeslerlab out. science.org/doi/10.1126/sc…
We provided the 2x Novavax immunized donor samples, which we extensively compared to mRNA and J&J vaccines for immune memory antibodies, CD4 T cells, CD8 T cells, and memory B cells in a recent paper sciencedirect.com/science/articl…
And it is good to see a new preprint from Penny Moore and colleagues with similar Novavax Omicron data.
Read 4 tweets
Mar 31, 2022
What parts of the immune system are protecting you against COVID? Immunology is complicated, so here's a graphic to try and explain it.
Layered defenses against SARS-CoV-2, or the “Swiss cheese” model of immunity. Image
Multiple types of adaptive immunity with diverse mechanisms likely provide layers of defense against COVID-19. Conceptually, these are like a “Swiss cheese model”: even though each layer is imperfect, together they keep the pathogen from breaching all layers of defense.
The graphic was inspired by the fantastic masking and public health layered defenses Swiss cheese model of @MackayIM.
Read 8 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(